ETS transcription factors: Possible targets for cancer therapy

被引：145

作者：

Oikawa, T ^{[1
]}

机构：

[1] Sasaki Inst, Dept Cell Genet, Chiyoda Ku, Tokyo 1010062, Japan

来源：

CANCER SCIENCE | 2004年 / 95卷 / 08期

关键词：

D O I：

10.1111/j.1349-7006.2004.tb03320.x

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Ets family (ETS) transcription factors, characterized by an evolutionally conserved Ets domain, play important roles in cell development, cell differentiation, cell proliferation, apoptosis and tissue remodeling. Most of them are downstream nuclear targets of Ras-MAP kinase signaling, and the deregulation of ETS genes results in the malignant transformation of cells. Several ETS genes are rearranged in human leukemia and Ewing tumors to produce chimeric oncoproteins. Furthermore, the aberrant expression of several ETS genes is often observed in various types of human malignant tumors. Considering that some ETS transcription factors are involved in malignant transformation and tumor progression, including invasion, metastasis and neo-angiogenesis through the activation of cancer-related genes, they could be potential molecular targets for selective cancer therapy.

引用

页码：626 / 633

页数：8

共 69 条

[1] Oligonucleotide therapeutics for hematologic disorders [J].

Agarwal, N ;

Gewirtz, AM .

BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1999, 1489 (01) :85-96

[2]

Agrawal D, 2002, J NATL CANCER I, V94, P513

[3] TRANSFORMING P21(RAS) MUTANTS AND C-ETS-2 ACTIVATE THE CYCLIN D1 PROMOTER THROUGH DISTINGUISHABLE REGIONS [J].

ALBANESE, C ;

JOHNSON, J ;

WATANABE, G ;

EKLUND, N ;

VU, D ;

ARNOLD, A ;

PESTELL, RG .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (40) :23589-23597

[4] Synergistic interactions between tamoxifen and trastuzumab (Herceptin) [J].

Argiris, A ;

Wang, CX ;

Whalen, SG ;

DiGiovanna, MP .

CLINICAL CANCER RESEARCH, 2004, 10 (04) :1409-1420

[5]

Bassuk AG, 1997, ADV IMMUNOL, V64, P65, DOI 10.1016/S0065-2776(08)60887-1

[6] Ets ternary complex transcription factors [J].

Buchwalter, G ;

Gross, C ;

Wasylyk, B .

GENE, 2004, 324 :1-14

[7] The PEA3 subfamily of Ets transcription factors synergizes with β-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors [J].

Crawford, HC ;

Fingleton, B ;

Gustavson, MD ;

Kurpios, N ;

Wagenaar, RA ;

Hassell, JA ;

Matrisian, LM .

MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (04) :1370-1383

[8] Analysis of the expression of cell cycle regulators in Ewing cell lines:: EWS-FLI-1 modulates p57KIP2 and c-Myc expression [J].

Dauphinot, L ;

De Oliveira, C ;

Melot, T ;

Sevenet, N ;

Thomas, V ;

Weissman, BE ;

Delattre, O .

ONCOGENE, 2001, 20 (25) :3258-3265

[9] Restoration of SMAD4 by gene therapy reverses the invasive phenotype in pancreatic adenocarcinoma cells [J].

Duda, DG ;

Sunamura, M ;

Lefter, LP ;

Furukawa, T ;

Yokoyama, T ;

Yatsuoka, T ;

Abe, T ;

Inoue, H ;

Motoi, F ;

Egawa, S ;

Matsuno, S ;

Horii, A .

ONCOGENE, 2003, 22 (44) :6857-6864

[10] TEL, a putative tumor suppressor, modulates cell growth and cell morphology of Ras-transformed cells while repressing the transcription of stromelysin-1 [J].

Fenrick, R ;

Wang, LL ;

Nip, J ;

Amann, JM ;

Rooney, RJ ;

Walker-Daniels, J ;

Crawford, HC ;

Hulboy, DL ;

Kinch, MS ;

Matrisian, LM ;

Hiebert, SW .

MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (16) :5828-5839

← 1 2 3 4 5 6 7 →